Targeting the endocannabinoid CB1 receptor to treat body weight disorders: a preclinical and clinical review of the therapeutic potential of past and present CB1 drugs

T Murphy, B Le Foll - Biomolecules, 2020 - mdpi.com
Obesity rates are increasing worldwide and there is a need for novel therapeutic treatment
options. The endocannabinoid system has been linked to homeostatic processes, including …

Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1 H-1, 2, 3-triazoles as inhibitors of Mycobacterium tuberculosis

SK Kancharla, S Birudaraju, A Pal, LK Reddy… - New Journal of …, 2022 - pubs.rsc.org
A series of fifteen novel isatin oxime ether-tethered aryl 1H-1, 2, 3-triazole hybrids 5a–o
were designed and synthesized by employing Cu (I) catalyzed azide–alkyne [3+ 2] …

The progress of small molecules against cannabinoid 2 receptor (CB2R)

Q Zhang, Y Zhao, J Wu, W Zhong, W Huang, Y Pan - Bioorganic Chemistry, 2024 - Elsevier
The two subtypes of cannabinoid receptors (CBR), namely CB 1 R and CB 2 R, belong to
the G protein-coupled receptor (GPCR) superfamily and are confirmed as potential …

Synthesis, characterization and antimicrobial evaluation of ferrocene–oxime ether benzyl 1 H-1, 2, 3-triazole hybrids

Y Swetha, ER Reddy, JR Kumar, R Trivedi… - New Journal of …, 2019 - pubs.rsc.org
A series of eight novel ferrocene–oxime ether benzyl 1H-1, 2, 3 triazole hybrids 5a–h were
designed and synthesized by employing Cu (I) catalyzed azide–alkyne [3+ 2] cycloaddition …

Cobalt‐Catalyzed Multi‐Substituted Alkene Synthesis from 1, 3‐Dithiolanes and Grignard Reagents

TA Davidson, S Anam, H Shi… - Asian Journal of Organic …, 2023 - Wiley Online Library
The cobalt‐catalyzed reaction between 1, 3‐dithiolanes and Grignard reagents, for the
efficient synthesis of multi‐substituted alkene products, is described. The method was …

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

IP Papanastasiou, MO Georgiadis… - European Journal of …, 2022 - Elsevier
In earlier work, we explored the SAR for the C3 side chain pharmacophore in the
hexahydrocannabinol template represented by the drug nabilone, which resulted in the …

Natural compounds and synthetic drugs to target type-1 cannabinoid (CB1) receptor

C Iliopoulos-Tsoutsouvas, MO Georgiadis, L Ji… - 2020 - books.rsc.org
Preparations of Cannabis sativa have been used in traditional medicine to treat various
conditions, such as pain, inflammation, and epilepsy, and for recreational purposes across …

Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments

A Kumar, O Gupta, R Bhatia… - Current Topics in …, 2023 - ingentaconnect.com
The Cannabinoid (CB) signalling cascade is widely located in the human body and is
associated with several pathophysiological processes. The endocannabinoid system …

The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats

SB Ogden, MS Malamas… - British Journal of …, 2019 - Wiley Online Library
Background and Purpose Δ9‐tetrahydrocannabinol (THC) acts via cannabinoid CB1
receptors to increase feeding. Here, we assessed the orexigenic effect of AM11101, a novel …

Natural Compounds and Synthetic Drugs to Target FAAH Enzyme

S Butini, S Gemma, G Campiani - 2020 - books.rsc.org
The fatty acid amide hydrolase (FAAH, EC 3.5. 1.99) is an integral intracellular membrane-
bound enzyme that was properly characterized in the mid-1980s, 1 although an N …